{
    "SPADE_UN_19044": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_19044",
            "Peptide Name": "RNST-2-G4K (RSP-4, Synthetic AMPs, retro-NST-2 analog, XXD, XXA, UCLL1c)",
            "Source": "amino acid substitution, designed, man-made sequences",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "FLKKLMGVIASLF",
            "Sequence Length": 13,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Antifungal",
                "Antifungal",
                "Anti-MRSA",
                "Anticancer"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 1466.87,
            "PI": 10.0,
            "Hydrophobicity": 1.57,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Abdullah SJ, Guan JS, Mu Y, Bhattacharjya S.2024",
                    "Reference": "Antibiotics (Basel). 2024 Dec 13;13(12):1213. doi: 10.3390/antibiotics13121213.PubMed",
                    "Title": "Synthesis of Temporin-SHa Retro Analogs with Lysine Addition/Substitution and Antibiotic Conjugation to Enhance Antibacterial, Antifungal, and Anticancer Activities."
                }
            ],
            "Frequent Amino Acids": "LFK",
            "Absent Amino Acids": "CDEHNOPQRTUWY",
            "Basic Residues": 2,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 9,
            "Polar Residues": 5,
            "Positive Residues": 2,
            "Negative Residues": 0,
            "Net Charge": 2,
            "Comments": "Sequence analysis: APD analysis reveals that this sequence is unique and shows only very low similarity (64.29%) toLausporin-1L:23%, K=F: 15%.Chemical modification: A10, D-amino acid;  C-terminal amidation.Activity: active against Gram+ S. aureus NCTC 13277 MRSA (MIC 50 uM), B. subtilis ATCC 23857 (MIC 12.5 uM), Gram- S. typhi ATCC 14028 (MIC 100 uM), E. coli ATCC 25922 (MIC 50 uM), P.aeruginosa ATCC 10145 (MIC 200 uM), and fungi C. albicans ATCC 36082 (MIC 100 uM).Structure:  helical in 20 mM SDS.In vitro toxicity: human RBC: HC50 >100 uM (not hemo.lytic at 100 uM). Breast cancer cells MCF-7 (IC50 39.9 uM), cervical cancer Hela cells (IC50 56.9 uM).",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_06495",
                    "Similarity": 1.0,
                    "Sequence": "VKKFAWWWAFLKK"
                },
                {
                    "SPADE_ID": "SPADE_N_06496",
                    "Similarity": 1.0,
                    "Sequence": "VKKFAWWWPFLKK"
                },
                {
                    "SPADE_ID": "SPADE_N_06497",
                    "Similarity": 1.0,
                    "Sequence": "VKKFPWWWAFLKK"
                }
            ]
        }
    }
}